VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AFGE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AFGEAmerican Financial Group, Inc.
$15.93$1.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAFGEQuarterly Financials

American Financial Group, Inc. (AFGE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

American Financial Group, Inc. (AFGE) quarterly income statement — complete revenue, gross profit & net income history

AFGE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.85B2.06B2.3B1.86B1.79B2.14B2.29B1.89B1.88B1.99B2.07B1.75B1.65B1.93B1.92B1.49B1.55B1.72B1.75B1.53B
Revenue Growth %3.69%-3.51%0.57%-1.17%-4.94%7.55%10.63%7.83%14.35%3.06%7.7%17.23%6.2%12.28%9.58%-2.55%5.37%5.92%13.02%-21.53%
Medical Costs & Claims01.06B00039M0-14M-25M0000-21M000000
Medical Cost Ratio %0%51.43%0%0%0%1.82%0%-0.74%-1.33%0%0%0%0%-1.09%0%0%0%0%0%0%
Gross Profit01B01.86B1.79B2.23B2.29B1.82B1.91B1.99B2.07B1.75B1.65B1.93B1.92B1.49B1.55B1.72B1.75B1.53B
Gross Margin %0%48.57%0%100%100%104.07%100%96.71%101.33%100%100%100%100%100%100%100%100%100%100%100%
Gross Profit Growth %-100%-54.97%-100%2.19%-6.19%11.92%10.63%4.29%15.87%3.06%7.7%17.23%6.2%12.28%9.58%-2.55%2.65%5.92%13.02%-21.53%
Operating Expenses0623M00041M01.52B168M36M000150M00041M-1.49B-1.24B
OpEx / Revenue %0%30.2%0%0%0%1.92%0%80.59%8.93%1.81%0%0%0%7.78%0%0%0%2.39%-84.78%-81.19%
Depreciation & Amortization022M20M00270M0-290M20M000022M000027M34M
Combined Ratio %0%81.63%0%0%0%3.74%0%79.85%7.6%1.81%0%0%0%6.69%0%0%0%2.39%-84.78%-81.19%
Operating Income0379M259M1.86B1.79B332M2.29B280M302M1.95B2.07B1.75B1.65B181M1.92B1.49B1.55B1.68B267M1.49B
Operating Margin %0%18.37%11.25%100%100%15.53%100%14.85%16.06%98.19%100%100%100%9.38%100%100%100%97.61%15.22%97.19%
Operating Income Growth %-100%14.16%-88.69%565.71%492.05%-82.99%10.63%-83.99%-81.64%978.45%7.7%17.23%6.2%-89.21%619.85%0.27%480.15%6.48%-82.8%404.41%
EBITDA0401M279M1.86B1.79B602M2.29B-10M322M1.95B2.07B1.75B1.65B203M1.92B1.49B1.55B1.68B294M1.52B
EBITDA Margin %0%19.44%12.11%100%100%28.16%100%-0.53%17.12%98.19%100%100%100%10.52%100%100%100%97.61%16.76%99.41%
Interest Expense23M23M19M19M19M19M19M19M19M45M19M19M19M20M19M23M23M024M23M
Non-Operating Income0-23M-28M1.86B1.79B-1M2.29B-14M-25M1.95B2.07B1.75B1.65B-21M1.92B1.49B1.55B1.68B-73M-75M
Pretax Income239M379M268M229M197M320M229M271M304M335M219M255M264M346M210M206M361M445M905M576M
Pretax Margin %12.89%18.37%11.64%12.29%11.02%14.97%10%14.37%16.16%16.85%10.58%14.58%16.05%17.94%10.93%13.81%23.31%25.9%51.6%37.62%
Income Tax48M80M53M55M43M65M48M62M62M72M42M55M52M70M45M39M71M90M48M48M
Effective Tax Rate %20.08%21.11%19.78%24.02%21.83%20.31%20.96%22.88%20.39%21.49%19.18%21.57%19.7%20.23%21.43%18.93%19.67%20.22%5.3%8.33%
Net Income191M299M215M174M154M255M181M209M242M263M177M200M212M276M165M167M290M355M905M1B
Net Margin %10.3%14.49%9.34%9.33%8.61%11.93%7.9%11.08%12.87%13.23%8.55%11.44%12.89%14.31%8.58%11.19%18.72%20.66%51.6%65.45%
Net Income Growth %24.03%17.25%18.78%-16.75%-36.36%-3.04%2.26%4.5%14.15%-4.71%7.27%19.76%-26.9%-22.25%-81.77%-83.33%-30.79%-48.7%451.83%466.1%
EPS (Diluted)2.293.592.582.081.843.032.162.492.893.142.092.352.483.241.931.963.404.1710.626.73
EPS Growth %24.46%18.48%19.44%-16.47%-36.33%-3.5%3.35%5.96%16.53%-3.09%8.29%19.9%-27.06%-22.3%-81.83%-70.88%-29.75%37.17%972.73%434.13%
EPS (Basic)2.293.582.572.081.843.042.162.492.893.142.092.352.493.241.941.963.414.1910.676.78
Diluted Shares Outstanding83.3M83.4M83.4M83.5M83.8M84M83.9M83.9M83.8M83.8M84.7M85.2M85.4M85.3M85.4M85.3M85.2M85.2M85.2M85.6M